BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34014910)

  • 1. Update to U.S. Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate.
    Curtis KM; Nguyen A; Reeves JA; Clark EA; Folger SG; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):739-743. PubMed ID: 34014910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
    Upadhyay UD; Zlidar VM; Foster DG
    Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
    Lancet Glob Health; 2018 May; 6(5):e568-e578. PubMed ID: 29526707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi.
    Burke HM; Packer C; Buluzi M; Healy E; Ngwira B
    Contraception; 2018 Nov; 98(5):405-410. PubMed ID: 29706227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
    Kohn JE; Berlan ED; Tang JH; Beasley A
    Contraception; 2022 Aug; 112():11-13. PubMed ID: 35378085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.
    Beasley A; White KO; Cremers S; Westhoff C
    Contraception; 2014 May; 89(5):352-6. PubMed ID: 24656555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
    Dragoman MV; Gaffield ME
    Contraception; 2016 Sep; 94(3):202-15. PubMed ID: 26874275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Katz M; Newmark RL; Aronstam A; O'Grady N; Strome S; Rafie S; Karlin J
    Contraception; 2020 Dec; 102(6):392-395. PubMed ID: 32931811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
    Contraception; 2018 Nov; 98(5):418-422. PubMed ID: 29758176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review.
    Aderoba AK; Steyn PS; Kiarie JN
    Syst Rev; 2023 Jul; 12(1):114. PubMed ID: 37403147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.
    Cover J; Ba M; Drake JK; NDiaye MD
    Contraception; 2019 Feb; 99(2):137-141. PubMed ID: 30439358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Burlando AM; Flynn AN; Gutman S; McAllister A; Roe AH; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2021 Oct; 138(4):574-577. PubMed ID: 34623069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
    MacLachlan E; Atuyambe LM; Millogo T; Guiella G; Yaro S; Kasasa S; Bukenya J; Nyabigambo A; Mubiru F; Tumusiime J; Onadja Y; Zan LM; Goeum/Sanon C; Kouanda S; Namagembe A
    Contraception; 2018 Nov; 98(5):423-429. PubMed ID: 30125558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable contraception: emerging evidence on subcutaneous self-administration.
    Lerma K; Goldthwaite LM
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):464-470. PubMed ID: 31567445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects.
    Liu J; Shen J; Diamond-Smith N
    Contraception; 2018 Nov; 98(5):430-437. PubMed ID: 29733817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector.
    Liu J; Schatzkin E; Omoluabi E; Fajemisin M; Onuoha C; Erinfolami T; Ayodeji K; Ogunmola S; Shen J; Diamond-Smith N; Sieverding M
    Contraception; 2018 Nov; 98(5):438-448. PubMed ID: 30071196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-care provision of contraception: Evidence and insights from contraceptive injectable self-administration.
    Brady M; Drake JK; Namagembe A; Cover J
    Best Pract Res Clin Obstet Gynaecol; 2020 Jul; 66():95-106. PubMed ID: 32199705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Santo LD; Ngwira B
    Glob Health Sci Pract; 2019 Mar; 7(1):54-65. PubMed ID: 30894394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood.
    Kohn JE; Simons HR; Della Badia L; Draper E; Morfesis J; Talmont E; Beasley A; McDonald M; Westhoff CL
    Contraception; 2018 Mar; 97(3):198-204. PubMed ID: 29246818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda.
    Di Giorgio L; Mvundura M; Tumusiime J; Morozoff C; Cover J; Drake JK
    Contraception; 2018 Nov; 98(5):396-404. PubMed ID: 30098940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.